Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 2026

    1.

    Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.

    Bergeron R, Previs SF, Cline GW, Perret P, Russell RR 3rd, Young LH, Shulman GI.

    Diabetes. 2001 May;50(5):1076-82.PMID: 11334411 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome.

    Buhl ES, Jessen N, Pold R, Ledet T, Flyvbjerg A, Pedersen SB, Pedersen O, Schmitz O, Lund S.

    Diabetes. 2002 Jul;51(7):2199-206.PMID: 12086950 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of AMPK activation on muscle glucose metabolism in conscious rats.

    Bergeron R, Russell RR 3rd, Young LH, Ren JM, Marcucci M, Lee A, Shulman GI.

    Am J Physiol. 1999 May;276(5 Pt 1):E938-44.PMID: 10329989 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo.

    Iglesias MA, Furler SM, Cooney GJ, Kraegen EW, Ye JM.

    Diabetes. 2004 Jul;53(7):1649-54.PMID: 15220186 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Portal venous 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output.

    Camacho RC, Pencek RR, Lacy DB, James FD, Donahue EP, Wasserman DH.

    Diabetes. 2005 Feb;54(2):373-82.PMID: 15677495 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscle.

    Smith AC, Bruce CR, Dyck DJ.

    J Physiol. 2005 Jun 1;565(Pt 2):547-53. Epub 2005 Mar 17.PMID: 15774529 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    AMP kinase-induced skeletal muscle glucose but not long-chain fatty acid uptake is dependent on nitric oxide.

    Shearer J, Fueger PT, Vorndick B, Bracy DP, Rottman JN, Clanton JA, Wasserman DH.

    Diabetes. 2004 Jun;53(6):1429-35.PMID: 15161745 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Interstitial muscle insulin and glucose levels in normal and insulin-resistant Zucker rats.

    Holmäng A, Mimura K, Björntorp P, Lönnroth P.

    Diabetes. 1997 Nov;46(11):1799-804.PMID: 9356029 [PubMed - indexed for MEDLINE]Related articles

    9.

    AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females.

    Steinberg GR, Smith AC, Van Denderen BJ, Chen Z, Murthy S, Campbell DJ, Heigenhauser GJ, Dyck DJ, Kemp BE.

    J Clin Endocrinol Metab. 2004 Sep;89(9):4575-80.PMID: 15356065 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    AMP kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting rat soleus muscle.

    Smith AC, Bruce CR, Dyck DJ.

    J Physiol. 2005 Jun 1;565(Pt 2):537-46. Epub 2005 Mar 17.PMID: 15774530 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.

    Jørgensen SB, Viollet B, Andreelli F, Frøsig C, Birk JB, Schjerling P, Vaulont S, Richter EA, Wojtaszewski JF.

    J Biol Chem. 2004 Jan 9;279(2):1070-9. Epub 2003 Oct 21.PMID: 14573616 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Contrasting effects of exercise, AICAR, and increased fatty acid supply on in vivo and skeletal muscle glucose metabolism.

    Rantzau C, Christopher M, Alford FP.

    J Appl Physiol. 2008 Feb;104(2):363-70. Epub 2007 Nov 21.PMID: 18032581 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats.

    Iglesias MA, Ye JM, Frangioudakis G, Saha AK, Tomas E, Ruderman NB, Cooney GJ, Kraegen EW.

    Diabetes. 2002 Oct;51(10):2886-94. Erratum in: Diabetes 2003 Jan;52(1):223-4. PMID: 12351423 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice.

    Song XM, Fiedler M, Galuska D, Ryder JW, Fernström M, Chibalin AV, Wallberg-Henriksson H, Zierath JR.

    Diabetologia. 2002 Jan;45(1):56-65.PMID: 11845224 [PubMed - indexed for MEDLINE]Related articles

    16.

    5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside reduces glucose uptake via the inhibition of Na+/H+ exchanger 1 in isolated rat ventricular cardiomyocytes.

    Ségalen C, Longnus SL, Baetz D, Counillon L, Van Obberghen E.

    Endocrinology. 2008 Apr;149(4):1490-8. Epub 2008 Jan 10.PMID: 18187546 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effects of stevioside on glucose transport activity in insulin-sensitive and insulin-resistant rat skeletal muscle.

    Lailerd N, Saengsirisuwan V, Sloniger JA, Toskulkao C, Henriksen EJ.

    Metabolism. 2004 Jan;53(1):101-7.PMID: 14681850 [PubMed - indexed for MEDLINE]Related articles

    19.

    Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations.

    Halseth AE, Ensor NJ, White TA, Ross SA, Gulve EA.

    Biochem Biophys Res Commun. 2002 Jun 21;294(4):798-805.PMID: 12061777 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data